A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.

Human FTO gene variants are associated with body mass index and type 2 diabetes. Because the obesity-associated SNPs are intronic, it is unclear whether changes in FTO expression or splicing are the cause of obesity or if regulatory elements within intron 1 influence upstream or downstream genes. We...

Full description

Bibliographic Details
Main Authors: Church, C, Lee, S, Bagg, E, McTaggart, J, Deacon, R, Gerken, T, Lee, A, Moir, L, Mecinovic, J, Quwailid, M, Schofield, C, Ashcroft, F, Cox, R
Format: Journal article
Language:English
Published: Public Library of Science 2009
_version_ 1826302890083352576
author Church, C
Lee, S
Bagg, E
McTaggart, J
Deacon, R
Gerken, T
Lee, A
Moir, L
Mecinovic, J
Quwailid, M
Schofield, C
Ashcroft, F
Cox, R
author_facet Church, C
Lee, S
Bagg, E
McTaggart, J
Deacon, R
Gerken, T
Lee, A
Moir, L
Mecinovic, J
Quwailid, M
Schofield, C
Ashcroft, F
Cox, R
author_sort Church, C
collection OXFORD
description Human FTO gene variants are associated with body mass index and type 2 diabetes. Because the obesity-associated SNPs are intronic, it is unclear whether changes in FTO expression or splicing are the cause of obesity or if regulatory elements within intron 1 influence upstream or downstream genes. We tested the idea that FTO itself is involved in obesity. We show that a dominant point mutation in the mouse Fto gene results in reduced fat mass, increased energy expenditure, and unchanged physical activity. Exposure to a high-fat diet enhances lean mass and lowers fat mass relative to control mice. Biochemical studies suggest the mutation occurs in a structurally novel domain and modifies FTO function, possibly by altering its dimerisation state. Gene expression profiling revealed increased expression of some fat and carbohydrate metabolism genes and an improved inflammatory profile in white adipose tissue of mutant mice. These data provide direct functional evidence that FTO is a causal gene underlying obesity. Compared to the reported mouse FTO knockout, our model more accurately reflects the effect of human FTO variants; we observe a heterozygous as well as homozygous phenotype, a smaller difference in weight and adiposity, and our mice do not show perinatal lethality or an age-related reduction in size and length. Our model suggests that a search for human coding mutations in FTO may be informative and that inhibition of FTO activity is a possible target for the treatment of morbid obesity.
first_indexed 2024-03-07T05:54:18Z
format Journal article
id oxford-uuid:e9fb712a-c294-4e9c-869a-65fc5fac26ff
institution University of Oxford
language English
last_indexed 2024-03-07T05:54:18Z
publishDate 2009
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:e9fb712a-c294-4e9c-869a-65fc5fac26ff2022-03-27T10:58:26ZA mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e9fb712a-c294-4e9c-869a-65fc5fac26ffEnglishSymplectic Elements at OxfordPublic Library of Science2009Church, CLee, SBagg, EMcTaggart, JDeacon, RGerken, TLee, AMoir, LMecinovic, JQuwailid, MSchofield, CAshcroft, FCox, RHuman FTO gene variants are associated with body mass index and type 2 diabetes. Because the obesity-associated SNPs are intronic, it is unclear whether changes in FTO expression or splicing are the cause of obesity or if regulatory elements within intron 1 influence upstream or downstream genes. We tested the idea that FTO itself is involved in obesity. We show that a dominant point mutation in the mouse Fto gene results in reduced fat mass, increased energy expenditure, and unchanged physical activity. Exposure to a high-fat diet enhances lean mass and lowers fat mass relative to control mice. Biochemical studies suggest the mutation occurs in a structurally novel domain and modifies FTO function, possibly by altering its dimerisation state. Gene expression profiling revealed increased expression of some fat and carbohydrate metabolism genes and an improved inflammatory profile in white adipose tissue of mutant mice. These data provide direct functional evidence that FTO is a causal gene underlying obesity. Compared to the reported mouse FTO knockout, our model more accurately reflects the effect of human FTO variants; we observe a heterozygous as well as homozygous phenotype, a smaller difference in weight and adiposity, and our mice do not show perinatal lethality or an age-related reduction in size and length. Our model suggests that a search for human coding mutations in FTO may be informative and that inhibition of FTO activity is a possible target for the treatment of morbid obesity.
spellingShingle Church, C
Lee, S
Bagg, E
McTaggart, J
Deacon, R
Gerken, T
Lee, A
Moir, L
Mecinovic, J
Quwailid, M
Schofield, C
Ashcroft, F
Cox, R
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title_full A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title_fullStr A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title_full_unstemmed A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title_short A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
title_sort mouse model for the metabolic effects of the human fat mass and obesity associated fto gene
work_keys_str_mv AT churchc amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT lees amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT bagge amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT mctaggartj amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT deaconr amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT gerkent amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT leea amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT moirl amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT mecinovicj amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT quwailidm amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT schofieldc amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT ashcroftf amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT coxr amousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT churchc mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT lees mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT bagge mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT mctaggartj mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT deaconr mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT gerkent mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT leea mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT moirl mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT mecinovicj mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT quwailidm mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT schofieldc mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT ashcroftf mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene
AT coxr mousemodelforthemetaboliceffectsofthehumanfatmassandobesityassociatedftogene